MNBTD
IRWD icon

Moody National Bank Trust Division’s Ironwood Pharmaceuticals IRWD Stock Holding History

Moody National Bank Trust Division’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-500
Closed -$4K – 1291
2018
Q4 		$4K Buy
+500
New +$5.74K ﹤0.01% 959

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Moody National Bank Trust Division's IRWD Position: Q1 2019 in Review

Moody National Bank Trust Division sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2019, closing a stake of 500 shares — an estimated $4K sold.

Moody National Bank Trust Division first reported a position in IRWD in Q4 2018 and held it in 1 quarter. The position peaked at $4K in Q4 2018. 156 funds tracked by Wall St. Rank hold IRWD as of Q1 2019.

  • Moody National Bank Trust Division reported no remaining Ironwood Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 500 Ironwood Pharmaceuticals shares in Q1 2019, an estimated $4K.
  • Moody National Bank Trust Division first reported a position in Ironwood Pharmaceuticals in Q4 2018 and held it in 1 quarter.
  • Moody National Bank Trust Division's Ironwood Pharmaceuticals position peaked at $4K in Q4 2018.
  • 156 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2019.

Based on Moody National Bank Trust Division's 13F filing for Q1 2019, filed 11 Apr 2019.